Holen Sie sich die Stockscreener-App
1.95
3.17%
0.06
Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten
Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock - Investing.com Nigeria
Opaleye management, a 10% owner, buys $123,819 of Grace Therapeutics stock - Investing.com
Form 4 Grace Therapeutics, Inc For: 6 October By Investing.com - Investing.com Nigeria
Form 4 Grace Therapeutics, Inc For: 6 October By Investing.com - Investing.com Canada
Form 4 Grace Therapeutics, Inc For: 6 October By Investing.com - Investing.com UK
Three purchases total 60,490 shares in Grace Therapeutics (GRCE) for Opaleye. - Stock Titan
At $2.09 a share, Opaleye buys 7,849 shares of Grace Therapeutics (GRCE). - Stock Titan
Ownership totals are corrected at Grace Therapeutics (GRCE) after purchases of 9,771 and 5,318 shares. - Stock Titan
Form 4 Grace Therapeutics, Inc For: 27 September By Investing.com - Investing.com Nigeria
Scienture Holdings, Inc. (SCNX) Stock Price & News - Syfe
Form 4 Grace Therapeutics, Inc For: 23 September By Investing.com - Investing.com Canada
Kairos Pharma, Ltd. (KAPA) Stock Price & News - Syfe
Grace Therapeutics director Opaleye Management buys $31,686 in stock - Investing.com
A fund bought 9,771 and 5,318 Grace Therapeutics (GRCE) shares in two purchases at $2.10 each. - Stock Titan
Form 4 Grace Therapeutics, Inc For: 22 September By Investing.com - Investing.com Nigeria
Grace Therapeutics Director A. Brian Davis Awarded 12,200 Stock Options - Kalkine Media
Grace Therapeutics Director Edward Neugeboren Granted Stock Options - Kalkine Media
Grace Therapeutics (GRCE) director gets 12,200 new stock options - Stock Titan
Grace Therapeutics (GRCE) gives director 12,200 stock options with one-year vesting - Stock Titan
Director at Grace Therapeutics (GRCE) awarded 12,200 stock options - Stock Titan
Investors at Grace Therapeutics (GRCE) choose annual say‑on‑pay vote - Stock Titan
Grace Therapeutics (GRCE) 10% holder buys more stock - Stock Titan
CEO Prashant Kohli Buys 100,000 Shares of Grace Therapeutics Inc (GRCE) - GuruFocus
Grace Therapeutics CEO Kohli acquires $214,000 in common stock - Investing.com
Grace Therapeutics CEO Kohli acquires $214,000 in common stock By Investing.com - Investing.com Canada
Grace Therapeutics CEO Kohli acquires $214,000 in common stock By Investing.com - Investing.com India
Grace Therapeutics CEO Kohli acquires $214,000 in common stock By Investing.com - Investing.com UK
Grace Therapeutics CEO Kohli acquires $214,000 in common stock - Investing.com
CEO of Grace Therapeutics (GRCE) adds 100K shares - Stock Titan
Grace Therapeutics CEO Kohli acquires $214,000 in common stock By Investing.com - Investing.com South Africa
Grace Therapeutics (GRCE) Dips 1.0% to $2.08, Holds Above Key SupportPullback Trade - dars.gov.et
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference - The Manila Times
A drug company CEO's presentation goes online Sept. 11. He'll meet investors in New York. - Stock Titan
Grace Therapeutics (GRCE) awards finance chief options vesting over three years - Stock Titan
Grace Therapeutics (GRCE) grants CEO options at $2.12 - Stock Titan
Grace Therapeutics, Inc. SEC Filing (Sep 1, 2026) - Stock Titan
Grace Therapeutics (GRCE) awards stock options to its chief medical officer - Stock Titan
Grace Therapeutics clears FDA safety hurdles for GTx-104 - scanx.trade
Opaleye Management Inc. Expands Stake in Grace Therapeutics Inc (GRCE) Despite Market Headwinds - GuruFocus
Grace TherapeuticsSelling Stockholders May Resell Up To 4,761,904 Shares Of Common StockSEC Filing - TradingView
Grace (GRCE) Quarterly Results: EPS Lands Above Forecast at the Close; Post-Earnings: The Stock Ends Up 2.80% in the Latest SessionCore Business Growth - vinanet.vn
Grace Therapeutics files prospectus for 4.762m share sale - scanx.trade
Grace Therapeutics Files for Resale of Up to 4.8 Million Shares - finance.yahoo.com
Grace (GRCE) Earnings Reading: EPS Exceeds Its Estimate in Latest Trading; Price Move: Shares Move 2.80% Higher - vinanet.vn
Grace (GRCE) Earnings Update: The Bottom-Line Figure Outpaces Its Comparison at the Close; Trading Response: Shares Finish 1.88% Higher in the Latest ReadingTech Earnings Analysis - vinanet.vn
Opaleye Management buys $24,206 of Grace Therapeutics stock By Investing.com - Investing.com Canada
Opaleye Management buys $24,206 of Grace Therapeutics stock - Investing.com
Opaleye Management buys $24,206 of Grace Therapeutics stock By Investing.com - Investing.com UK
Opaleye Management buys $24,206 of Grace Therapeutics stock - Investing.com
Grace Therapeutics (GRCE) holder lifts indirect stake to 2.76M shares - Stock Titan
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):